![Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00680/article_deploy/html/images/pharmaceuticals-15-00680-ag.png?1654847024)
Pharmaceuticals | Free Full-Text | In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
![Freie Kappa-Leichtketten als Biomarker für Schubrisiko? - Medizin/Therapie - Multiple Sklerose News - AMSEL e.V. Freie Kappa-Leichtketten als Biomarker für Schubrisiko? - Medizin/Therapie - Multiple Sklerose News - AMSEL e.V.](https://www.amsel.de/fileadmin/_processed_/a/1/csm_schubf%C3%B6rmig-remittierender-verlauf-multiple-sklerose-diagramm-orange_0da187994b.jpg)
Freie Kappa-Leichtketten als Biomarker für Schubrisiko? - Medizin/Therapie - Multiple Sklerose News - AMSEL e.V.
Bestimmung der leichten Kappa- und Lambda-Ketten im Serum ergibt einen Mehrwert in der Diagnostik Plasmazellerkrankungen
![Molecules | Free Full-Text | Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor Molecules | Free Full-Text | Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor](https://pub.mdpi-res.com/molecules/molecules-28-00718/article_deploy/html/images/molecules-28-00718-ag.png?1673609615)